February 10, 2012
1 min read
Save

PS250 Survey

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Click here for the results of the answer to the following questions.

Which presbyopic IOL are you most excited to see gain U.S. Food and Drug Administration approval?

What is your most common enhancement technique for patients with a residual refractive error after implantation of a multifocal IOL?